NIH-funded research R03 grant

Investigating how FOXM1 contributes to eosinophilic esophagitis

Official title: The Role of FOXM1 in Eosinophilic Esophagitis Pathogenesis

Funded at Children's Hosp of Philadelphia · NIH-10724896 · Data updated 2026-11-12

This study is looking at how a protein called FOXM1 might cause problems in the esophagus for people with eosinophilic esophagitis (EoE), which makes it hard to swallow, and aims to find new ways to help improve treatments for this condition.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionChildren's Hosp of Philadelphia
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 1, 2023
Project endJuly 31, 2025
Funding year2023
Award (this year)$178,000
NIH project number1R03TR004578-01
Project IDNIH-10724896 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with eosinophilic esophagitis who experience symptoms such as dysphagia or food impaction.

Less likely to help

Patients without eosinophilic esophagitis or those with other unrelated gastrointestinal disorders may not benefit from this research.

What this research studies

This research focuses on eosinophilic esophagitis (EoE), a chronic allergic condition affecting the esophagus, leading to symptoms like difficulty swallowing and food impaction. The study aims to understand the role of a protein called FOXM1 in disrupting the normal function of esophageal cells, which may contribute to inflammation and other complications in EoE. Using advanced cell culture techniques, researchers will explore how FOXM1 affects the behavior of esophageal cells when exposed to specific inflammatory signals. The ultimate goal is to identify potential therapeutic targets that could improve treatment options for patients suffering from this condition.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that alleviate symptoms and improve the quality of life for patients with eosinophilic esophagitis.

How similar studies have gone: Previous research has shown promising results in understanding the role of inflammatory pathways in eosinophilic esophagitis, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Children's Hosp of Philadelphia
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Muir, Amanda Brooke — Children's Hosp of Philadelphia
  • Study coordinator: Muir, Amanda Brooke

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.